0
0
8/15/25 at 10:10pm
Organization
STAT
Author
Elaine Chen
32 words
0
Comments
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.
You are the first to view
https://www.statnews.com/2025/08/15/wegovy-mash-novo-nordisk/
Create an account
or login to join the discussion